Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign or malignant neoplasm that occurs in sella turcica. Representative examples include craniopharyngioma and pituitary gland adenoma.
Biomarker and diagnostic research for sella turcica neoplasm has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include medical devices and procedural interventions. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
108 publications have been identified in PubMed for sella turcica neoplasm. Research spans Case Report / Case Series (34%), Clinical Trial Publication (28%), and Review / Meta-Analysis (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 37 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 3:08 AM UTC
Clinical study results | 30 | 28% |
Research summaries | 13 | 12% |
Laboratory research | 13 | 12% |
Testing and diagnosis research | 10 | 9% |
Disease patterns and progression | 5 | 5% |
Uzuner A (2026). [PMID: 42225019](https://pubmed.ncbi.nlm.nih.gov/42225019/). *J Clin Neurosci*. [Review / Meta-Analysis]
Spinek AE (2026). [PMID: 42263470](https://pubmed.ncbi.nlm.nih.gov/42263470/). *Int J Paleopathol*. [Case Report / Case Series]
Laure C (2026). [PMID: 41655900](https://pubmed.ncbi.nlm.nih.gov/41655900/). *Ann Endocrinol (Paris)*. [Case Report / Case Series]
Wu J (2026). [PMID: 41719552](https://pubmed.ncbi.nlm.nih.gov/41719552/). *J Neurosurg*. [Clinical Trial Publication]
Morisako H (2026). [PMID: 42220193](https://pubmed.ncbi.nlm.nih.gov/42220193/). *No Shinkei Geka*. [Review / Meta-Analysis]
Wu H (2026). [PMID: 41966303](https://pubmed.ncbi.nlm.nih.gov/41966303/). *World Neurosurg*. [Case Report / Case Series]
Watanabe T (2026). [PMID: 42036867](https://pubmed.ncbi.nlm.nih.gov/42036867/). *No Shinkei Geka*. [Review / Meta-Analysis]
Hall WA (2026). [PMID: 32644525](https://pubmed.ncbi.nlm.nih.gov/32644525/). *Unknown Journal*. [Review / Meta-Analysis]
Munger DN (2026). [PMID: 41784185](https://pubmed.ncbi.nlm.nih.gov/41784185/). *Turk Neurosurg*. [Epidemiology / Natural History]
Tong T (2026). [PMID: 41419183](https://pubmed.ncbi.nlm.nih.gov/41419183/). *Endocr Pract*. [Diagnostic / Biomarker]